Connected With Latham

78 Episodes

1. Episode 58 – FDI Developments: M&A Security Screening in Europe's Fragmented FDI Landscape

   Published: 10/24/2023
2. Episode 57 – Drug Pricing: What Trends Emerged from the 2023 Medicaid Drug Rebate Program Summit?

   Published: 10/20/2023
3. Episode 56 – M&A Views: Avoiding Buyer’s Remorse in M&A Deals

   Published: 9/27/2023
4. Episode 55 – Insurtech: What Should Startups Do After Receiving FCA Authorization?

   Published: 9/21/2023
5. Episode 54 – Drug Pricing: Focus on Best Price — CMS Proposed Rule, Inflation Reduction Act

   Published: 9/15/2023
6. Episode 53 – Energy & Infrastructure: Can Sustainable Finance Fuel the Energy Transition?

   Published: 8/30/2023
7. Episode 52 – Drug Pricing: Could a Single Reference Price Apply Across a Therapeutic Class?

   Published: 8/21/2023
8. Episode 51 – Drug Pricing: Final IRA Price Negotiation Guidance – How CMS Addressed the Part D/B Problem

   Published: 7/31/2023
9. Episode 50 – PE Views: Under New Reforms, Is the Customer Always Right?

   Published: 7/14/2023
10. Episode 49 – PE Views: Will Greenwashing Rain on the UK PE Parade?

    Published: 6/20/2023
11. Episode 48 – M&A Views: Will UK-Bound M&A Need to Come to US Terms?

    Published: 4/27/2023
12. Episode 47 – Real Estate Realities in Europe: Expensive Money and the Power of Private Equity

    Published: 4/17/2023
13. Episode 46 – PE Views: PE Must Strike the Right Balance With Unions

    Published: 3/31/2023
14. Episode 45 – Will Insurtech Reach New Heights in 2023?

    Published: 3/8/2023
15. Episode 44 – PE Views: Private Equity Looks to Share-Based Schemes to Incentivise Non-Managerial Staff

    Published: 1/20/2023
16. Episode 43 – Energy & Infrastructure: The Drivers and Opportunities of Asia’s Digital Infrastructure Boom

    Published: 11/1/2022
17. Episode 42 – PE Views: Has Rethinking Cannabis Sparked PE Interest?

    Published: 7/11/2022
18. Episode 41 – PE Views: Why Do Music Deals Sound So Attractive to PE?

    Published: 6/9/2022
19. Episode 40 – PE Views: Could PE Benefit From the Universal Adoption of “Super Senior” RCFs in Leveraged Financings?

    Published: 4/28/2022
20. Episode 39 – New FDA Commissioner Dr. Califf: What His Appointment Means for the Regulated Industry and What to Watch for in 2022

    Published: 2/15/2022